Healthcare
Snared by Drug Companies

Snared by Drug Companies

Drug companies are cashing in on the epidemic of mental illness spawned by the psychiatric industry. But is this a case of the cure being worse than the disease? ...
Rebecca Terrell

Dateline: Ontario, Canada. Eighteen-year-old Brennan McCartney visited his doctor for a chest cold and, despite no history of mental health issues or diagnosis of depression, received a prescription for the antidepressant Cipralex. Four days later, on November 8, 2010, he hanged himself.

Dateline: Laytonsville, Maryland. A psychiatrist prescribed the antidepressant Zoloft to 12-year-old Candace Downing, who suffered anxiety related to schoolwork but was otherwise a bright child with a loving family, a wide circle of friends, and no history of depression. On January 10, 2004, her mother found her dead, hanging from her bed valance.

Dateline: Indianapolis, Indiana. To help pay her college tuition, 19-year-old Traci Johnson volunteered for a clinical trial of a new antidepressant called Cymbalta. On February 7, 2004, she hanged herself at the Eli Lilly laboratory where the experiment was held. She was one of five participants who took their lives during clinical trials of the drug prior to its debut, though all had been pre-screened to confirm they did not have mental problems.

This fantastic article is for subscribers only.
Login
Lost Password?

JBS Member or ShopJBS.org Customer?

Sign in with your ShopJBS.org account username and password or use that login to subscribe.

The New American Digital Subscription The New American Digital Subscription Subscribe Now
Use code SUB25 at check out
  • 24 Issues Per Year
  • Digital Edition Access
  • Exclusive Subscriber Content
  • Audio provided for all articles
  • Unlimited access to past issues
  • Cancel anytime.
  • Renews automatically
The New American Print+Digital Subscription The New American Print+Digital Subscription Subscribe Now
Use code SUB25 at check out
  • 24 Issues Per Year
  • Print edition delivery (USA)
    *Available Outside USA
  • Digital Edition Access
  • Exclusive Subscriber Content
  • Audio provided for all articles
  • Unlimited access to past issues
  • Cancel anytime.
  • Renews automatically